News And Announcements
WSP to buy RPS in £591m deal
Shares of professional services firm RPS Group surged on Tuesday after it agreed to be bought by rival WSP for around £591. 1m.
Legal & General operating profit rises 8%
UK insurer Legal & General lifted interim operating profits on Tuesday, driven by higher interest rates and a strong annuity portfolio performance.
IWG narrows first-half losses amid 'strong' demand for hybrid working
Workspace provider IWG reported a narrowing of its first-half losses on Tuesday amid strong demand for hybrid working.
Coca-Cola HBC to acquire ESM Effervescent Sodas
Beverage company Coca-Cola Hellenic Bottling has agreed to acquire ESM Effervescent Sodas from Greece's IDEAL Holdings' wholly-owned SICC Holdings subsidiary.
Abrdn posts drop in first-half profits, cautious on outlook
Asset manager Abrdn posted a drop in first-half profit and revenue on Tuesday and struck a cautious note on the outlook.
Home prices drive 13% rise in Bellway housing revenues
House builder Bellway on Tuesday reported a 13% rise in annual housing revenue rose, driven by strong home prices which offset pressure from higher costs.
IHG profits double as travel rebounds from Covid curbs
InterContinental Hotels Group doubled interim profits, reinstated dividends and announced a $500m share buyback as travel demand increased after Covid restrictions eased.
Avast H1 EBITDA drops as margins contract
Cybersecurity provider Avast said on Tuesday that underlying earnings had dropped in the six months ended 30 June as margins contracted and revenues remained broadly flat year-on-year.
Ryanair threatens legal action against Hungary over 'unjustfied' fine
Low-cost airline Ryanair said it would take the Hungarian government to court after it was fined for passing an "unjustified" windfall tax onto customers.
Good Energy investment Zap-Map completes £9m series-A round
Renewable electricity supplier Good Energy announced on Monday that electric vehicle charging point mapping service Zap-Map has completed a £9m series-A fundraising, valuing Zap-Map at a £26. 3m post-money equity value.
WH Smith secures pension de-risking deal with Standard Life
WH Smith's pension fund on Monday said it had insured the benefits of all its pension members in a deal with Standard Life.
Solid State completes acquisition of LA-based Custom Power
Computing, power and communications value-added component supplier Solid State has completed the acquisition of Custom Power, it announced on Monday.
Anglo Asian Mining joins Libero Copper's private placement
Azerbaijan-focussed gold, copper and silver producer Anglo Asian Mining has made a further investment in Libero Copper & Gold Corporation, it announced on Monday.
Tertiary Minerals sells Finnish royalties to Canada's Aurion
Tertiary Minerals has accepted a binding offer from Aurion Resources for the purchase of its royalty interests in the Kaaresselkä and Kiekerömaa gold projects in Finland, it announced on Monday.
Egdon, Union Jack confirm appeal to Lincolnshire council planning refusal
Egdon Resources and Union Jack Oil both told shareholders on Monday that an appeal against a refusal by the Lincolnshire County Council had been submitted.
Pfizer to buy Global Blood Therapeutics in $5.4bn deal
Pfizer has agreed to buy biopharmaceutical group Global Blood Therapeutics for $5. 4bn in cash.
Seed Innovations puts another £50k into South West Brands
Medical cannabis, health and wellness-focussed investor Seed Innovations has invested a further £50,000 in London-based wellness and beauty brand owner South West Brands (SWB), it announced on Monday.
Michael Lynch-Bell appointed as new Serabi Gold chair
Brazil-focussed miner and developer Serabi Gold announced the appointment of Michael Lynch-Bell as a non-executive director and its new chairman on Monday, with immediate effect.
R&Q reports strong premiums growth in first half
Non-life specialty insurance company R&Q reported gross written premiums of $807m in a first-half update on Monday, up 82% year-on-year.
Hutchmed upbeat on latest study results for colorectal cancer treatment
Hutchmed China announced on Monday that the “pivotal” global phase three trial evaluating the investigational use of ‘fruquintinib’ met its primary endpoint of overall survival in patients with advanced, refractory metastatic colorectal cancer (CRC).